跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SAXENDA liraglutide (rys) 6mg/mL solution for injection, pre-filled pen - TGA Drug Approval Details
Approvals
/
TGA
/
SAXENDA liraglutide (rys) 6mg/mL solution for injection, pre-filled pen
Approved
STANDARD
SAXENDA liraglutide (rys) 6mg/mL solution for injection, pre-filled pen
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
139de442981deb4a
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
139de442981deb4a
Product Name
SAXENDA liraglutide (rys) 6mg/mL solution for injection, pre-filled pen
Artg Id
225804
Artg Name
SAXENDA liraglutide (rys) 6mg/mL solution for injection pre-filled pen
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2015-12-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/508c8a262b85dbbb886958c28b8bcfcc.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ec1fbdde8ac4ecee9c620e42c0f704c6.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
139de442981deb4a
Type
Standard
Back to TGA Approvals